<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Sunsense Ultra" /><meta name="IX" content="Sunsense Ultra" /><title>Sunsense® Ultra: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP7910-sunsense-ultra.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP7910-sunsense-ultra.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP7910-sunsense-ultra.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 07 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP7449-skin.htm">13 Skin</a> &gt; <a href="PHP7902-sunscreens-and-camouflagers.htm">13.8 Sunscreens and camouflagers</a> &gt; <a href="PHP7903-sunscreen-preparations.htm">13.8.1 Sunscreen preparations</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP7902-sunscreens-and-camouflagers.htm" title="Previous: 13.8 Sunscreens and camouflagers">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP7912-photodamage.htm" title="Next: Photodamage">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1><span>13.8.1 </span>Sunscreen preparations</h1><?highlighter on?><div id="pC" class="jN"><p>Solar ultraviolet irradiation can be harmful to the skin. It is responsible for disorders such as <em>polymorphic light eruption, solar urticaria</em>, and it provokes the various <em>cutaneous porphyrias</em>. It also provokes (or at least aggravates) skin lesions of <em>lupus erythematosus</em> and may aggravate <em>rosacea</em> and some other <em>dermatoses</em>. Certain drugs, such as demeclocycline, phenothiazines, or amiodarone, can cause photosensitivity. All these conditions (as well as <em>sunburn</em>) may occur after relatively short periods of exposure to the sun. Solar ultraviolet irradiation may provoke attacks of recurrent herpes labialis (but it is not known whether the effect of sunlight exposure is local or systemic).</p> <p>The effects of exposure over longer periods include <em>ageing changes</em> and more importantly the initiation of <em>skin cancer</em>.</p> <p>Solar ultraviolet radiation is approximately 200–400 nm in wavelength. The medium wavelengths (290–320 nm, known as UVB) cause <em>sunburn</em>. The long wavelengths (320–400 nm, known as UVA) are responsible for many <em>photosensitivity reactions</em> and <em>photodermatoses</em>. Both UVA and UVB contribute to long-term <em>photodamage</em> and to the changes responsible for <em>skin cancer</em> and ageing.</p> <p id="PHP7904">Sunscreen preparations contain substances that protect the skin against UVA and UVB radiation, but they are no substitute for covering the skin and avoiding sunlight. The sun protection factor (SPF, usually indicated in the preparation title) provides guidance on the degree of protection offered against UVB; it indicates the multiples of protection provided against burning, compared with unprotected skin; for example, an SPF of 8 should enable a person to remain 8 times longer in the sun without burning. However, in practice, users do not apply sufficient sunscreen product and the protection is lower than that found in experimental studies.</p> <p>Some manufacturers use a star rating system to indicate the protection against UVA relative to protection against UVB for sunscreen products. However, the usefulness of the star rating system remains controversial. The EU Commission (September 2006) has recommended that the UVA protection factor for a sunscreen should be at least one-third of the sun protection factor (SPF); products that achieve this requirement will be labelled with a UVA logo alongside the SPF classification. Preparations that also contain reflective substances, such as titanium dioxide, provide the most effective protection against UVA.</p> <p>Sunscreen preparations may rarely cause allergic reactions.</p> <div class="cI"><p>For optimum photoprotection, sunscreen preparations should be applied <strong>thickly </strong>and <strong>frequently</strong> (approximately 2 hourly). In photodermatoses, they should be used from spring to autumn. As maximum protection from sunlight is desirable, preparations with the highest SPF should be prescribed.</p></div> <div class="table" id="PHP7905"> <div class="cAA">Ingredient nomenclature in sunscreen preparations<span></span><span></span></div> <table class="table" summary="Ingredient nomenclature in sunscreen preparationsINCI synonyms, sunscreensInternational nomenclature, cosmetic ingredients see INCI synonyms" cellspacing="0" cellpadding="8" border="0" style="border-collapse: collapse;border-top: 1pt solid ; border-bottom: 1pt solid ; border-left: 1pt solid ; border-right: 1pt solid ; "><colgroup><col style="text-align: left;" /><col style="text-align: left;" /></colgroup><thead><tr><th style="border-bottom: 1pt solid ; text-align: left;">rINN</th><th style="border-bottom: 1pt solid ; text-align: left;">INCI</th></tr></thead><tbody><tr><td style="border-bottom: 1pt solid ; text-align: left;">amiloxate</td><td style="border-bottom: 1pt solid ; text-align: left;">isoamyl <em>p</em>-methoxycinnamate</td></tr><tr><td style="border-bottom: 1pt solid ; text-align: left;">avobenzone</td><td style="border-bottom: 1pt solid ; text-align: left;">butyl methoxydibenzoylmethane</td></tr><tr><td style="border-bottom: 1pt solid ; text-align: left;">bemotrizinol</td><td style="border-bottom: 1pt solid ; text-align: left;">bis-ethylhexyloxyphenol methoxyphenyl triazine</td></tr><tr><td style="border-bottom: 1pt solid ; text-align: left;">bisoctrizole</td><td style="border-bottom: 1pt solid ; text-align: left;">methylene bis-benzotriazolyl tetramethylbutylphenol</td></tr><tr><td style="border-bottom: 1pt solid ; text-align: left;">ecamsule</td><td style="border-bottom: 1pt solid ; text-align: left;">terephthalylidene dicamphor sulfonic acid</td></tr><tr><td style="border-bottom: 1pt solid ; text-align: left;">ensulizole</td><td style="border-bottom: 1pt solid ; text-align: left;">phenylbenzimidazole sulfonic acid</td></tr><tr><td style="border-bottom: 1pt solid ; text-align: left;">enzacamene</td><td style="border-bottom: 1pt solid ; text-align: left;">4-methylbenzylidene camphor</td></tr><tr><td style="border-bottom: 1pt solid ; text-align: left;">octinoxate</td><td style="border-bottom: 1pt solid ; text-align: left;">octyl (<em>or</em> ethylhexyl) methoxycinnamate</td></tr><tr><td style="border-bottom: 1pt solid ; text-align: left;">octocrilene</td><td style="border-bottom: 1pt solid ; text-align: left;">octocrylene</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-bottom: 1pt solid ; text-align: left;">oxybenzone</td><td style="border-bottom: 1pt solid ; text-align: left;">benzophenone-3</td></tr><tr><td style="border-bottom: 1pt solid ; text-align: left;" colspan="2">The European Commission Cosmetic Products Regulation (EC) 1223/2009 requires the use of INCI (International Nomenclature of Cosmetic Ingredients) for cosmetics and sunscreens. This table includes the rINN and the INCI synonym for the active ingredients of sunscreen preparations in the BNF</td></tr></tbody></table></div> <div><h2>Borderline substances</h2><p>The preparations marked ‘ACBS’ are regarded as drugs when prescribed for skin protection against ultraviolet radiation in abnormal cutaneous photosensitivity resulting from genetic disorders or photodermatoses, including vitiligo and those resulting from radiotherapy; chronic or recurrent herpes simplex labialis. Preparations with SPF less than 30 should not normally be prescribed. See also <a title="BNF:target-block: Conditions (photodermatoses)" href="PHP9291-conditions-for-which-acbs-products-can-be-prescribed.htm#PHP9292">Appendix 2</a>.</p></div> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="PHP7907-anthelios.htm#PHP7907-anthelios" title="Anthelios®">Anthelios®</a></li><li><a href="PHP7908-delph.htm#PHP7908-delph" title="Delph®">Delph®</a></li></ul><div id="PHP7910-sunsense-ultra" style="margin: 0 0 0 20px;"><h1 class="title">Sunsense® Ultra <span>(<a href="PHP10005-index-of-manufacturers.htm#PHP10106">Crawford</a>)</span></h1><div class="cU"><p><strong>Lotion</strong>  (UVA and UVB protection; UVB-SPF 50+), octinoxate 6%, enzacamene 4%, avobenzone 2%, oxybenzone 2%, ensulizole 2%, titanium dioxide 3%, net price 50-mL bottle with roll-on applicator = £4.44, 125 mL = £7.22, 500-mL pump pack = £16.12. ACBS</p><p class="cR"><span class="cAD">Excipients </span>include butylated hydroxytoluene, cetyl alcohol, fragrance, hydroxybenzoates (parabens), propylene glycol</p><div class="cG"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">For INCI synonyms, see table <a title="BNF:target-block: Ingredient nomenclature in sunscreen preparations table" href="PHP7903-sunscreen-preparations.htm#PHP7905">above</a></p></div></div></div></div><ul class="jT"><li><a href="PHP7911-uvistat.htm#PHP7911-uvistat" title="Uvistat®">Uvistat®</a></li><li id="_PHP7912-photodamage"><a href="PHP7912-photodamage.htm" title="Photodamage">Photodamage</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP7902-sunscreens-and-camouflagers.htm">Previous: 13.8 Sunscreens and camouflagers</a> | <a class="top" href="PHP7910-sunsense-ultra.htm#">Top</a> | <a accesskey="]" href="PHP7912-photodamage.htm">Next: Photodamage</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>